Mitochondrial/Nuclear Transfer: A Literature Review of the Ethical, Legal and Social Issues

Mitochondrial/nuclear transfer (M/NT) to avoid the transmission of serious mitochondrial disease raises complex and challenging ethical, legal and social issues (ELSI). In February 2015, the United Kingdom became the first country in the world to legalize M/NT, making the heated debate surrounding this technology even more relevant. This critical interpretive review identified 95 relevant papers discussing the ELSI of M/NT, including original research articles, government-commissioned reports, editorials, letters to editors and research news. The review presents and synthesizes the arguments present in the literature in relation to the most commonly raised themes: terminology; identity, relationships and parenthood; potential harm; reproductive autonomy; available alternatives; consent; impact on specific interest groups; resources; “slippery slope”; creation, use and destruction of human embryos; and beneficence. The review concludes by identifying those ELSI that are specific to M/NT and by calling for follow-up longitudinal clinical and psychosocial research in order to equip future ELSI debate with empirical evidence.

[1]  Martin H. Johnson,et al.  First birth following spindle transfer for mitochondrial replacement therapy: hope and trepidation. , 2017, Reproductive biomedicine online.

[2]  A. Chavez-Badiola,et al.  Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. , 2017, Reproductive biomedicine online.

[3]  V. Ravitsky,et al.  The “Three-Parent Baby”: A Case Study of How Language Frames the Ethical Debate Regarding an Emerging Technology , 2015, The American journal of bioethics : AJOB.

[4]  Pei-Lun Chu,et al.  Three-parent embryo: The therapeutic future for inherited mitochondrial diseases. , 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

[5]  S. Wilkinson,et al.  Mitochondrial Replacement: Ethics and Identity , 2015, Bioethics.

[6]  R. McDougall.  Reviewing Literature in Bioethics Research: Increasing Rigour in Non‐Systematic Reviews , 2015, Bioethics.

[7]  J. Appleby.  The ethical challenges of the clinical introduction of mitochondrial replacement techniques , 2015, Medicine, health care, and philosophy.

[8]  D. Sperling,et al.  Mitochondrial replacement therapy and parenthood , 2015 .

[9]  J. Loike,et al.  Mitochondrial Replacement Therapy: Halachic Considerations for Enrolling in an Experimental Clinical Trial , 2015, Rambam Maimonides medical journal.

[10]  S. Mclean.  Mitochondrial DNA Transfer. Some Reflections from the United Kingdom , 2015 .

[11]  A. Bredenoord,et al.  The road to mitochondrial gene transfer: follow the middle lane. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  N. Gemmell,et al.  Mitochondrial replacement therapy: Cautiously replace the master manipulator , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  W. Dondorp,et al.  A leap of faith? An interview study with professionals on the use of mitochondrial replacement to avoid transfer of mitochondrial diseases. , 2015, Human reproduction.

[14]  M. Herbert,et al.  Mitochondrial replacement to prevent the transmission of mitochondrial DNA disease , 2015, EMBO reports.

[15]  G. Allahbadia.  Is the World of ART Ready for a Ménage à Trois? , 2015, The Journal of Obstetrics and Gynecology of India.

[16]  Jd,et al.  Reproductive technologies and the new math: When it takes three parents to make an embryo , 2015 .

[17]  Z. Kmietowicz.  UK becomes first country to allow mitochondrial donation , 2015, BMJ : British Medical Journal.

[18]  L. Hyslop,et al.  Concise Reviews: Assisted Reproductive Technologies to Prevent Transmission of Mitochondrial DNA Disease , 2015, Stem cells.

[19]  G. Vogel.  U.K. Parliament approves controversial three-parent mitochondrial gene therapy , 2015 .

[20]  J. Wise.  Mitochondrial donation could benefit 150 UK women a year, study says , 2015, BMJ : British Medical Journal.

[21]  M. Sauer,et al.  Controversies concerning mitochondrial replacement therapy. , 2015, Fertility and sterility.

[22]  S. Mitalipov,et al.  Mitochondrial replacement therapy in reproductive medicine. , 2015, Trends in molecular medicine.

[23]  S. Fischer.  State of the ART : Emerging genetic technologies in reproductive medicine are rapidly making real what once was science fiction?are we ready for it? , 2015, IEEE Pulse.

[24]  S. Grossman.  Mitochondrial Replacement Therapy and Jewish Law , 2015 .

[25]  J. R. Fernando.  Three's Company: A Constitutional Analysis of Prohibiting Access to Three-Parent In Vitro Fertilization , 2015 .

[26]  Ruth L. Fischbach,et al.  Creating a Three-Parent Child: An Educational Paradigm for the Responsible Conduct of Research , 2014, Journal of microbiology & biology education.

[27]  Sarah Norcross.  How and why mitochondrial replacement gets our vote. , 2014, Reproductive biomedicine online.

[28]  G. Pennings.  International harmonization and mitochondrial replacement. , 2014, Reproductive biomedicine online.

[29]  Martin H. Johnson,et al.  Therapy for mitochondrial genetic disease: are we at the thin end of the wedge? , 2014, Reproductive biomedicine online.

[30]  F. Flinter.  Concerning Tetsuya Ishii's article: potential impact of human mitochondrial replacement on global policy regarding germline gene modification. , 2014, Reproductive biomedicine online.

[31]  T. Ishii.  Potential impact of human mitochondrial replacement on global policy regarding germline gene modification. , 2014, Reproductive biomedicine online.

[32]  I. Torjesen.  Government gives the go ahead for mitochondrial donation during IVF , 2014, BMJ : British Medical Journal.

[33]  J. Wise.  Mitochondrial donation is “not unsafe,” review confirms , 2014, BMJ : British Medical Journal.

[34]  E. Callaway.  Reproductive medicine: The power of three , 2014, Nature.

[35]  A. Paller.  Are You My Mother? Why Mitochondrial DNA Transfers Require States to Rework Traditional, Two-Person Legal Parentage Frameworks , 2014 .

[36]  J. Wise.  Draft UK regulations for mitochondrial donation are published , 2014, BMJ : British Medical Journal.

[37]  G. Vogel.  Assisted reproduction. FDA considers trials of 'three-parent embryos'. , 2014, Science.

[38]  S. Mitalipov,et al.  Clinical and ethical implications of mitochondrial gene transfer , 2014, Trends in Endocrinology & Metabolism.

[39]  Mitochondrial manipulations , 2014, Nature Medicine.

[40]  Padmini Cheruvu.  Three-Parent IVF and Its Effect on Parental Rights , 2014 .

[41]  S. Mitalipov,et al.  Three-parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases. , 2014, Fertility and sterility.

[42]  I. Johnston,et al.  Review of the safety and efficacy of polar body transfer to avoid mitochondrial disease Addendum to ‘ Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception : 2014 update , 2014 .

[43]  D. Egli,et al.  Harnessing the Stem Cell Potential: The path to prevent mitochondrial disease , 2013, Nature Medicine.

[44]  H. Smeets.  Preventing the transmission of mitochondrial DNA disorders: selecting the good guys or kicking out the bad guys. , 2013, Reproductive biomedicine online.

[45]  M. Legge,et al.  Numerical identity: the creation of tri-parental embryos to correct inherited mitochondrial disease. , 2013, The New Zealand medical journal.

[46]  E. Hayden.  Regulators weigh benefits of ‘three-parent’ fertilization , 2013, Nature.

[47]  K. Reinhardt,et al.  Mitochondrial Replacement, Evolution, and the Clinic , 2013, Science.

[48]  M. Darnovsky.  A slippery slope to human germline modification , 2013, Nature.

[49]  F. Baylis.  The ethics of creating children with three genetic parents. , 2013, Reproductive biomedicine online.

[50]  S. Mayor.  Chief medical officer advises government to allow mitochondrial replacement to prevent disease , 2013, BMJ.

[51]  Martin H. Johnson,et al.  Tri-parenthood--a simply misleading term or an ethically misguided approach? , 2013, Reproductive biomedicine online.

[52]  I. Holme,et al.  Relatively (im) material: mtDNA and genetic relatedness in law and policy , 2013, Life Sciences, Society and Policy.

[53]  R. Dimond.  Patient and family trajectories of mitochondrial disease: diversity, uncertainty and genetic risk , 2013, Life Sciences, Society and Policy.

[54]  R. Briscoe.  Ethical Considerations, Safety Precautions and Parenthood in Legalising Mitochondrial Donation , 2013, The New bioethics : a multidisciplinary journal of biotechnology and the body.

[55]  D. Dickenson.  The Commercialization of Human Eggs in Mitochondrial Replacement Research , 2013, The New bioethics : a multidisciplinary journal of biotechnology and the body.

[56]  A. Sutton.  A Case against Germ-Line Gene Therapy , 2013 .

[57]  P. Oakeshott,et al.  Nuclear transfer to prevent maternal transmission of mitochondrial DNA disease , 2012, BMJ : British Medical Journal.

[58]  T. Lancet.  Ethics of mitochondrial donation , 2012, The Lancet.

[59]  N. Hawkes.  Intervention to prevent transmission of mitochondrial disorders should be allowed, subject to safeguards, report says , 2012, BMJ : British Medical Journal.

[60]  V. Ravitsky.  Conceived and deceived: the medical interests of donor-conceived individuals. , 2012, The Hastings Center report.

[61]  Human Genetic Engineering on the Doorstep The threat of ‘ mitochondrial replacement ’ techniques November , 2012 .

[62]  A. Bredenoord,et al.  Nuclear transfer to prevent mitochondrial DNA disorders: revisiting the debate on reproductive cloning. , 2011, Reproductive biomedicine online.

[63]  A. Bredenoord,et al.  Ethics of modifying the mitochondrial genome , 2010, Journal of Medical Ethics.

[64]  A. Bredenoord,et al.  Ethics of mitochondrial gene replacement: from bench to bedside , 2010, BMJ : British Medical Journal.

[65]  A. Bredenoord,et al.  Avoiding transgenerational risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? , 2010, Human reproduction.

[66]  D. Cyranoski.  DNA swap could avoid inherited diseases , 2009 .

[67]  A. Bredenoord,et al.  Ooplasmic and nuclear transfer to prevent mitochondrial DNA disorders: conceptual and normative issues. , 2008, Human reproduction update.

[68]  N. Lane.  One baby, two mums , 2008 .

[69]  Laura C. Greaves,et al.  Mitochondrial DNA mutations in human disease , 2006, IUBMB life.

[70]  G. Bongaerts.  How to prevent 'half-bastard' progeny? or An alternative for three-parent babies: two-parent babies through transplantation of sperm mitochondria. , 2006, Medical hypotheses.

[71]  E. Schon,et al.  Response to “Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman (CQ Vol 4, No 3) , 1999, Cambridge Quarterly of Healthcare Ethics.

[72]  H. Haker,et al.  Some Conceptual and Ethical Comments on Egg Cell Nuclear Transfer , 1998, Politics and the Life Sciences.

[73]  E. Schon,et al.  Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation , 1995, Cambridge Quarterly of Healthcare Ethics.

[74]  P. Burnard.  A method of analysing interview transcripts in qualitative research. , 1991, Nurse education today.